These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 561857)
1. Superiority of adriamycin-14-octanoate over adriamycin in reducing viability of methotrexate-resistant L5178Y cells: brief communication. Hill BT; Price LA J Natl Cancer Inst; 1977 Oct; 59(4):1311-4. PubMed ID: 561857 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448 [TBL] [Abstract][Full Text] [Related]
3. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
4. Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells. Mandelbaum-Shavit F; Ramu A Cell Biol Int Rep; 1987 May; 11(5):389-96. PubMed ID: 3607890 [TBL] [Abstract][Full Text] [Related]
5. The value of adriamycin in overcoming resistance to methotrexate in tissue culture. Hill BT; Price LA; Goldies JH Eur J Cancer (1965); 1976 Jul; 12(7):541-9. PubMed ID: 986302 [No Abstract] [Full Text] [Related]
6. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis. Chitnis MP; Johnson RK J Natl Cancer Inst; 1978 May; 60(5):1049-54. PubMed ID: 642026 [TBL] [Abstract][Full Text] [Related]
7. Effect of adriamycin on the reproductive integrity of cultured leukemia L1210 and P388 cells. Wilkott LJ; Dulmadge EA; Lloyd HH J Natl Cancer Inst; 1978 May; 60(5):1117-20. PubMed ID: 565414 [TBL] [Abstract][Full Text] [Related]
8. Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia. Ramu A; Fridkin M; Steinherz R Cancer Chemother Pharmacol; 1985; 15(1):31-4. PubMed ID: 4006047 [TBL] [Abstract][Full Text] [Related]
9. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559 [TBL] [Abstract][Full Text] [Related]
10. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells]. Shimizu T Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482 [TBL] [Abstract][Full Text] [Related]
11. Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Müller WE; Seibert G; Beyer R; Breter HJ; Maidhof A; Zahn RK Cancer Res; 1977 Oct; 37(10):3824-33. PubMed ID: 332340 [No Abstract] [Full Text] [Related]
12. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Johnson RK; Chitnis MP; Embrey WM; Gregory EB Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555 [TBL] [Abstract][Full Text] [Related]
13. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies on N-benzyladriamycin-14-valerate (AD 198), a highly lipophilic alkyl adriamycin analog. Lameh J; Chuang LF; Israel M; Chuang RY Anticancer Res; 1988; 8(4):689-93. PubMed ID: 3052250 [TBL] [Abstract][Full Text] [Related]
15. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance and cross-sensitivity in cultured human osteosarcoma cells. Tomita K; Kontani T; Tsuchiya H; Nomura S Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):274-81. PubMed ID: 2738428 [TBL] [Abstract][Full Text] [Related]
17. Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells. Chuang LF; Chuang RY; Acton EM; Israel M; Yu M J Pharmacol Exp Ther; 1987 Jul; 242(1):372-7. PubMed ID: 2441029 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
19. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Inaba M; Kobayashi H; Sakurai Y; Johnson RK Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418 [TBL] [Abstract][Full Text] [Related]
20. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells. Adwankar MK; Chitnis MP Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]